We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
Cap. Flow
-$2.68B
Cap. Flow %
-3.48%
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Industrials 9.36%
3 Consumer Discretionary 8.52%
4 Healthcare 7.75%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFE icon
3226
PUT
New Fortress Energy
NFE
$101M
-225,500
Closed -$257K
NGD
3227
DELISTED
New Gold Inc
NGD
-10,467,113
Closed -$91.2M
NGG icon
3228
National Grid
NGG
$82.7B
-8,316
Closed -$643K
NHI icon
3229
National Health Investors
NHI
$3.9B
-131,772
Closed -$10.1M
NJR icon
3230
New Jersey Resources
NJR
$6.06B
-69,302
Closed -$3.2M
NLY icon
3231
Annaly Capital Management
NLY
$16.9B
-930,294
Closed -$20.8M
NMCO icon
3232
Nuveen Municipal Credit Opportunities Fund
NMCO
$579M
-55,468
Closed -$567K
NMRK icon
3233
Newmark Group
NMRK
$2.73B
-2,039,976
Closed -$35.4M
NNI icon
3234
Nelnet
NNI
$4.79B
-5,411
Closed -$719K
NOC icon
3235
PUT
Northrop Grumman
NOC
$77B
-5,600
Closed -$3.19M
NOTV
3236
DELISTED
Inotiv
NOTV
-1,471,849
Closed -$827K
NRDS icon
3237
NerdWallet
NRDS
$584M
-30,110
Closed -$408K
NRIX icon
3238
Nurix Therapeutics
NRIX
$2.43B
-118,481
Closed -$2.25M
NTES icon
3239
CALL
NetEase
NTES
$76.5B
-1,600
Closed -$220K
NTES icon
3240
NetEase
NTES
$76.5B
-119,303
Closed -$16.4M
NTNX icon
3241
CALL
Nutanix
NTNX
$14.9B
-400,000
Closed -$20.7M
NTR icon
3242
CALL
Nutrien
NTR
$32.7B
-8,600
Closed -$531K
NTR icon
3243
Nutrien
NTR
$32.7B
-4,137
Closed -$255K
NTR icon
3244
PUT
Nutrien
NTR
$32.7B
-28,600
Closed -$1.77M
NTST
3245
NETSTREIT Corp
NTST
$2.16B
-333,590
Closed -$5.88M
NUE icon
3246
CALL
Nucor
NUE
$56.4B
-100,000
Closed -$16.3M
NVAX icon
3247
CALL
Novavax
NVAX
$1.23B
-482,700
Closed -$3.24M
NVAX icon
3248
Novavax
NVAX
$1.23B
-384,991
Closed -$2.59M
XMAX
3249
XMAX Inc
XMAX
$536M
-14,602
Closed -$87.6K
NVS icon
3250
Novartis
NVS
$295B
-5,404
Closed -$745K

Similar funds

Balyasny Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.

  • Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
  • Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
  • Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
  • Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
  • Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
  • Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
  • Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.